This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Radian Group (RDN) Q1 Earnings Top Estimates, Decrease Y/Y
by Zacks Equity Research
Radian Group's (RDN) Q1 results reflect high monthly premium policy insurance in force and declining single premiums policy insurance in force. High expenses act as an offset.
MGIC Investment (MTG) Q1 Earnings Top on Higher Persistency
by Zacks Equity Research
MGIC Investment's (MTG) Q1 results benefit from higher insurance in force and net investment income. Meanwhile, higher expenses and lower premiums partially offset the positives.
Assurant (AIZ) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Assurant's (AIZ) first-quarter results reflect higher net earned premiums, fees and other income and net investment income, offset by improved expenses and catastrophe events.
Assurant (AIZ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of 55.11% and 2.22%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q1 Earnings Due on May 2: AIZ, PRU & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive first-quarter results of insurers like AIZ, PRU, UNM, RNR and AFG.
Assurant (AIZ) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Assurant's (AIZ) first-quarter results are likely to benefit from higher average insured values, lender-placed growth within Global Housing, higher fixed maturity yields and expansion across distribution channels.
Earnings Preview: Assurant (AIZ) Q1 Earnings Expected to Decline
by Zacks Equity Research
Assurant (AIZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 19th
by Zacks Equity Research
AIZ, EQX and FRC have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.
New Strong Sell Stocks for April 12th
by Zacks Equity Research
ASLE, AIZ and EQX have been added to the Zacks Rank #5 (Strong Sell) List on April 12, 2023.
Assurant (AIZ) Down 7.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Assurant (AIZ) Banks on Solid Segmental Growth Amid Cost Woes
by Zacks Equity Research
Assurant (AIZ) holds the potential to reap benefits driven by policies in force, favorable mobile loss experience and higher income on fixed maturity securities.
EverQuote (EVER) Q4 Earnings Beat on Lower Operating Expense
by Zacks Equity Research
EverQuote's (EVER) Q4 results witness lower revenues from the Automotive and Other insurance verticals due to the inability to raise premium rates quickly. Lower operating expenses act as an offset.
Horace Mann (HMN) Q4 Earnings and Revenues Beat, Shares Dip
by Zacks Equity Research
Horace Mann's (HMN) bottom line deteriorates due to the poor performance in the Property and Casualty segment, partially offset by improving performance in its other two comparatively stable segments.
CNO Financial's (CNO) Shares Rise 2% on Q4 Earnings Beat
by Zacks Equity Research
CNO Financial's (CNO) fourth-quarter results indicate growing annuity collected premiums along with lower benefits and expenses.
New Strong Sell Stocks for February 13th
by Zacks Equity Research
CIVI, AIZ and HMN have been added to the Zacks Rank #5 (Strong Sell) List on February 13, 2023.
Assurant (AIZ) Q4 Earnings & Revenues Beat, Premiums Rise Y/Y
by Zacks Equity Research
Assurant's (AIZ) Q4 results reflect higher average insured values, premium rates and lender-placed policies in force and growth in Connected Living, partly offset by higher expenses.
Assurant (AIZ) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of 24.71% and 1.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 2.48% and 0.37%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Assurant (AIZ) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Assurant's (AIZ) Q4 earnings sre likely to benefit from device protection growth in North America, growth in Specialty and Other products and Lender-placed Insurance, and higher fixed maturity asset levels.
Assurant (AIZ) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Assurant (AIZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for December 21st
by Zacks Equity Research
AIZ, CBRL and GIII have been added to the Zacks Rank #5 (Strong Sell) List on December 21, 2022.
New Strong Sell Stocks for December 19th
by Zacks Equity Research
ARCE, CVE and AIZ have been added to the Zacks Rank #5 (Strong Sell) List on December 19, 2022.
New Strong Sell Stocks for December 13th
by Zacks Equity Research
ACCO, ASIX and AIZ have been added to the Zacks Rank #5 (Strong Sell) List on December 13, 2022.
AXIS Capital (AXS) Okays Share Buyback, Ups Dividend by 2.3%
by Zacks Equity Research
AXIS Capital's (AXS) recent dividend hike and share buyback approval reflects its intention to enhance shareholders' value supported by its strong financial position.
Erie Indemnity (ERIE) OK's Dividend Hike to Share More Profits
by Zacks Equity Research
Erie Indemnity's (ERIE) recent dividend hike reflects its solid capital position and balance sheet strength that continue to support effective capital deployment.